Human Cord Blood Stem Cells Enhance Neonatal Right Ventricular Function in an Ovine Model of Right Ventricular Training

Annals of Thoracic Surgery

Volumn 89, Issue 2, 2010, Pages

  Davies, Ben ^a,b   Elwood, Ngaire J ^a   Li, Shan ^a   Cullinane, Fiona ^a   Edwards, Glenn A ^a   Newgreen, Donald F ^a   Brizard, Christian P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BETA ACTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DNA EXTRACTION; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMICS; HISTOLOGY; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHEEP; STEM CELL; UMBILICAL CORD BLOOD;

EID: 74549135132     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.10.035     Document Type: Article

References (36)

1. Piran S., Veldtman G., Siu S., Webb G.D., and Liu P.P. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation 105 (2002) 1189-1194
2. Roos-Hesselink J.W., Meijboom F.J., Spitaels S.E., et al. Decline in ventricular function and clinical condition after mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J 25 (2004) 1264-1270
3. Li W., Hornung T.S., Francis D.P., et al. Relation of biventricular function quantified by stress echocardiography to cardiopulmonary exercise capacity in adults with mustard (atrial switch) procedure for transposition of the great arteries. Circulation 110 (2004) 1380-1386
4. Stasik C.N., Gelehrter S., Goldberg C.S., Bove E.L., Devaney E.J., and Ohye R.G. Current outcomes and risk factors for the Norwood procedure. J Thorac Cardiovasc Surg 131 (2006) 412-417
5. Voelkel N.F., Quaife R.A., Leinwand L.A., et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114 (2006) 1883-1891
6. Koh G.Y., Klug M.G., Soonpaa M.H., and Field L.J. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 92 (1993) 1548-1554
7. Leor J., Guetta E., Feinberg M.S., et al. Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells 24 (2006) 772-780
8. Perin E.C., Dohmann H.F., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
9. Perin E.C., Dohmann H.F., Borojevic R., et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110 Suppl 1 (2004) II-213-II-218
10. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
11. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
12. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 (2005) 367-368
13. Olivetti G., Ricci R., Lagrasta C., Maniga E., Sonnenblick E.H., and Anversa P. Cellular basis of wall remodeling in long-term pressure overload-induced right ventricular hypertrophy in rats. Circ Res 63 (1988) 648-657
14. Thompson J.T., Rackley M.S., and O'Brien T.X. Upregulation of the cardiac homeobox gene Nkx2-5 (CSX) in feline right ventricular pressure overload. Am J Physiol 274 (1998) H1569-H1573
15. Bauer E.P., Kuki S., Zimmermann R., and Schaper W. Upregulated and downregulated transcription of myocardial genes after pulmonary artery banding in pigs. Ann Thorac Surg 66 (1998) 527-531
16. Bar H., Kreuzer J., Cojoc A., and Jahn L. Upregulation of embryonic transcription factors in right ventricular hypertrophy. Basic Res Cardiol 98 (2003) 285-294
17. Urashima T., Zhao M., Wagner R., et al. Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. Am J Physiol Heart Circ Physiol 295 (2008) H1351-H1368
18. Wong K., Boheler K.R., Petrou M., and Yacoub M.H. Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix, and gene expression. Circulation 96 (1997) 2239-2246
19. Leeuwenburgh B.P., Helbing W.A., Steendijk P., Schoof P.H., and Baan J. Biventricular systolic function in young lambs subject to chronic systemic right ventricular pressure overload. Am J Physiol Heart Circ Physiol 281 (2001) H2697-H2704
20. Hon J.K., Steendijk P., Petrou M., Wong K., and Yacoub M.H. Influence of Clenbuterol treatment during six weeks of chronic right ventricular pressure overload as studied with pressure-volume analysis. J Thorac Cardiovasc Surg 122 (2001) 767-774
21. Emani S.M., Shah A.S., White D.C., Glower D.D., and Koch W.J. Right ventricular gene therapy with a β-adrenergic receptor kinase inhibitor improves survival after pulmonary artery banding. Ann Thorac Surg 72 (2001) 1657-1661
22. Broxmeyer H.E. Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy 7 (2005) 209-218
23. Broxmeyer H.E., Douglas G.W., Hangoc G., et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 86 (1989) 3828-3832
24. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337 (1997) 373-381
25. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 354 (2006) 1813-1826
26. Robinson S., Niu T., de Lima M., et al. Ex vivo expansion of umbilical cord blood. Cytotherapy 7 (2005) 243-250
27. Zanjani E.D., Pallavicini M.G., Ascensao J.L., et al. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 89 (1992) 1178-1188
28. Pixley J.S., Tavassoli M., Zanjani E.D., et al. Transplantation in utero of fetal human hematopoietic stem cells into mice results in hematopoietic chimerism. Pathobiology 62 (1994) 238-244
29. Shimizu Y., Ogawa M., Kobayashi M., Almeida-Porada G., and Zanjani E.D. Engraftment of cultured human hematopoietic cells in sheep. Blood 91 (1998) 3688-3692
30. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6 (2000) 1282-1286
31. Elwood N.J., Jiang X.R., Chiu C.P., Lebkowski J.S., and Smith C.A. Enhanced long-term survival, but no increase in replicative capacity, following retroviral transduction of human cord blood CD34+ cells with human telomerase reverse transcriptase. Haematologica 89 (2004) 377-378
32. Suga H., Sagawa K., and Shoukas A.A. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 32 (1973) 314-322
33. Burkhoff D., Mirsky I., and Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 289 (2005) H501-H512
34. Gentry T., and Smith C. Retroviral vector-mediated gene transfer into umbilical cord blood CD34brCD38-CD33-cells. Exp Hematol 27 (1999) 1244-1254
35. McNiece I.K., Almeida-Porada G., Shpall E.J., and Zanjani E. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 30 (2002) 612-616
36. Zanjani E.D., Almeida-Porada G., and Flake A.W. The human/sheep xenograft model: a large animal model of human hematopoiesis. Int J Hematol 63 (1996) 179-192